Cytokinetics | CYTK - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Acadia Pharmaceuticals USD 160.79M 14.06M 2026-03
Amgen USD 1.58B 354M 2026-03
Arca Biopharma USD 2.23M 1.08M 2025-12
Bayer EUR 3.7B 356M 2026-03
Biogen USD 709.7M 155.4M 2026-06
Brainstorm Cell Therapeutics USD 1.39M 326K 2025-12
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Capricor Therapeutics USD 1.92M 446.47K 2025-12
Cytokinetics USD 104.9M 13.17M 2026-03
Eisai JPY 119.54B 7.82B 2026-03
Eli Lilly USD 2.93B 198M 2026-03
Exelixis USD 139.6M 16.58M 2026-03
Geron USD 35.42M 6.24M 2026-03
Halozyme Therapeutics USD 46.29M 18.35M 2026-03
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
Ligand Pharmaceuticals USD 20.84M 4.19M 2026-03
Merck USD 2.67B 180M 2026-03
Novartis USD 3.24B 101M 2026-06
Pfizer USD 2.92B 1.16B 2026-03
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.63B 307M 2026-06